Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 13.20 billion as of August 15, 2025. Its market cap has decreased by -19.19% in one year.

Market Cap

13.20B

Enterprise Value

11.67B

Revenue

662.47M

Ranking

n/a

PE Ratio

n/a

Stock Price

40.15

Market Cap Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 13.20B, an increase of 365.58%. That is a compound annual growth rate of 16.57%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	13.20B	11.38%
Dec 31, 2024	11.85B	-48.55%
Dec 29, 2023	23.04B	1.10%
Dec 30, 2022	22.78B	-64.20%
Dec 30, 2021	63.65B	192.75%
Dec 31, 2020	21.74B	388.97%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	224.90B
PharmaEssentia	167.97B
Bora Pharmaceuticals Co., LTD.	97.17B
Lotus Pharmaceutical	52.73B
Oneness Biotech	34.00B
Lumosa Therapeutics	28.78B
Polaris Group	27.23B
Center Laboratories	26.78B

Market Cap Rankings